Shinghwa Advanced Material (SH:603026)2024-10-28 12:14Financial Performance - The company's operating revenue for Q3 2024 was ¥1,539,675,535.64, representing a decrease of 0.09% compared to the same period last year[2]. - The net profit attributable to shareholders for Q3 2024 was a loss of ¥26,792,090.38, a decline of 152.61% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2024 was a loss of ¥28,822,356.36, down 158.45% from the previous year[2]. - The basic earnings per share for Q3 2024 was -¥0.13, a decrease of 152.00% compared to the same period last year[3]. - Total operating revenue for the first three quarters of 2024 was CNY 4,160,688,757.41, a decrease of 5.43% compared to CNY 4,399,374,393.98 in the same period of 2023[14]. - Net profit attributable to shareholders of the parent company for the first three quarters of 2024 was CNY 11,265,103.68, compared to CNY 70,190,858.57 in the same period of 2023, indicating a significant decline[15]. - The company reported a net loss of CNY 63,277,216.25 for the third quarter of 2024, compared to a net profit of CNY 18,565,467.63 in the same quarter of 2023[15]. - The company’s total comprehensive income for the third quarter of 2024 was CNY -63,277,216.25, compared to CNY 18,565,467.63 in the same quarter of 2023, indicating a significant decline[16]. Assets and Liabilities - The total assets at the end of the reporting period were ¥9,423,761,555.53, an increase of 29.52% compared to the end of the previous year[3]. - The total liabilities as of the end of the third quarter of 2024 amounted to CNY 5,102,734,177.02, an increase from CNY 2,890,643,441.59 at the end of the same period in 2023[12]. - The total equity attributable to shareholders at the end of the reporting period was ¥3,899,264,278.55, a slight increase of 0.22% from the previous year[3]. - The total equity attributable to shareholders of the parent company was CNY 3,899,264,278.55, slightly up from CNY 3,890,544,142.70 year-over-year[12]. Cash Flow - The net cash flow from operating activities for the year-to-date was -¥327,123,513.82, a decrease of 72.86%[3]. - In the first three quarters of 2024, the cash inflow from operating activities was approximately ¥4.16 billion, a decrease of 21.6% compared to ¥5.30 billion in the same period of 2023[17]. - The net cash outflow from operating activities for the first three quarters of 2024 was approximately -¥327.12 million, compared to -¥187.08 million in the same period of 2023[19]. - The cash inflow from financing activities was approximately ¥2.20 billion, an increase from ¥733.72 million in the first three quarters of 2023[20]. - The total cash and cash equivalents at the end of the period was approximately ¥1.42 billion, up from ¥836.51 million at the end of the same period in 2023[20]. Operational Metrics - The company reported a significant decline in gross profit margins for the methyl tert-butyl ether series, impacting overall profitability[7]. - Research and development expenses for the first three quarters of 2024 were CNY 160,969,441.19, an increase from CNY 138,787,264.41 in the previous year, reflecting a growth of 15.06%[14]. - The company received government subsidies amounting to ¥2,800,456.13 during the reporting period[4]. Shareholder Information - The company had 40,799 common shareholders at the end of the reporting period[8]. - The company has not reported any changes in the participation of major shareholders in margin trading and securities lending activities during the reporting period[10].